FASLG and autoimmune polyendocrinopathy: Prevalence of aPL in healthy asymptomatic individuals is 1–5% for anti-CL and 3% for anti-β2GPI.38 The predictive value for APS clinical events in asymptomatic carriers has been addressed by few studies.